ST. PAUL, Minn.--(BUSINESS WIRE)--BioE®, Inc., a biomedical company providing human umbilical cord blood stem cells as enabling, high-quality cellular tools for drug discovery and therapeutic research, announced today a report published in the latest issue (Vol. 8, Issue 5) of the journal Cytotherapy confirms its Multi-Lineage Progenitor Cell™ (MLPC™) is the first human cord blood stem cell to differentiate into a type II alveolar lung cell.
